CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 24 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $20,000 | -13.0% | 24,467 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $23,000 | -47.7% | 24,467 | 0.0% | 0.00% | -40.0% |
| Q1 2018 | $44,000 | +22.2% | 24,467 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $36,000 | -30.8% | 24,467 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $52,000 | +52.9% | 24,467 | 0.0% | 0.01% | +50.0% |
| Q2 2017 | $34,000 | -12.8% | 24,467 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $39,000 | – | 24,467 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $10,573,000 | 10.68% |
| Clarus Ventures, LLC | 2,752,488 | $10,184,000 | 8.91% |
| Rhenman & Partners Asset Management AB | 345,100 | $1,277,000 | 0.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 203,243 | $752,000 | 0.20% |
| Camber Capital Management LP | 1,000,000 | $3,700,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 643,580 | $2,381,000 | 0.09% |
| FT Options LLC | 15,059 | $56,000 | 0.05% |
| FRED ALGER MANAGEMENT, LLC | 86,782 | $321,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 27,700 | $102,000 | 0.00% |
| FIRST NEW YORK SECURITIES LLC /NY | 750 | $2,775,000 | 0.00% |